Alaunos Therapeutics shares are trading lower after the company announced a 1-for-10 reverse stock split.
Portfolio Pulse from Benzinga Newsdesk
Alaunos Therapeutics shares are trading lower after the company announced a 1-for-10 reverse stock split.
July 18, 2024 | 4:13 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Alaunos Therapeutics shares are trading lower after the company announced a 1-for-10 reverse stock split.
Reverse stock splits are often perceived negatively by investors as they can indicate underlying financial issues. This perception has led to a drop in Alaunos Therapeutics' share price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100